During the past decade, JPM van Stralen Medicine Professional Corporation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "JPM van Stralen Medicine Professional Corporation" are "Attention Deficit Hyperactivity Disorder" (1 trials) and "Attention-deficit/Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "JPM van Stralen Medicine Professional Corporation" in a lesser frequency.

Most popular intervention types in "JPM van Stralen Medicine Professional Corporation" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Extended-release Guanfacine Hydrochloride" (1 trials), "Guanfacine extended release" (1 trials) and "Stimulant therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "JPM van Stralen Medicine Professional Corporation" are 2 trials for "All" genders.

Currently, there are NaN active trials in "JPM van Stralen Medicine Professional Corporation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in JPM van Stralen Medicine Professional Corporation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in JPM van Stralen Medicine Professional Corporation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".